Market Value: Amneal Corp (AMRX)

Official company branding of Amneal Corp (AMRX)

Amneal Pharmaceuticals (AMRX) supply chains are vulnerable due to a reliance on raw material shipments from Asia and geopolitical risks. This daily price chart, which currently shows a level of 7.46, correlates with successes in biosimilar production and Parkinson's disease treatment. Strong ties with pharmacies and the indispensability of core medications ensure business stability despite stringent FDA oversight.

AMRX (Amneal) Market Capitalization history from 07/04/2022 to 11/16/2026

Comprehensive metric breakdowns and analytics for Amneal Pharmaceuticals (AMRX)

- market price and analyst price targets:
Fundamental company analysis:AMRX (Amneal Pharmaceuticals Inc)
Product sample of Amneal Corp

For investors, the market position of Amneal Pharmaceuticals (AMRX) is determined by its success in the biosimilars and complex injectables segments, which directly impacts capitalization as an integral measure of business value. An analysis of the company's total value chart allows for an assessment of the market consensus regarding margin growth rates and debt reduction, where the product of the share price and the total number of shares captures the issuer's current fundamental valuation.

Key competitors

Market Value Haleon Group HLN|Kenvue Inc. - Market Value|VRNA - Market Value|MENS (jyongbio.com) - Market Capitalization|LGND: Market Capitalization|Market Value Perrigo Company PLC (PRGO)|Market Value Alvotech SA|Liquidia Technologies - Market Valuation|Market Capitalization GLPG|ANIP (ANI Pharmaceuticals) - Market Value|Market Capitalization MNKD (mannkindcorp.com)|Market Capitalization Amphastar Pharmaceuticals Inc AMPH|PCRX - Market Value|Market Value SPRY (ARS Corp)|theravance.com (TBPH) - Market Value|Market Valuation Aquestive Therapeutics|SCPH (scPharma) - Market Capitalization|Market Capitalization Tectonic Therapeutic|Market Valuation TNXP (Tonix Pharmaceuticals Inc.)|SXTC (SXT Pharmaceuticals) - Market Value|Market Value Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc. (BHST) - Market Value|EXOZ: Market Valuation|oramed.com - Market Value|ENTX: Market Capitalization|MindWalk - Market Value|ABVC (ABVC BioPharma Inc.) - Market Capitalization|Market Value cumberlandpharma.com CPIX|Market Value Quantum BioPharma (QNTM)|FGEN (FibroGen) - Market Value|Telomir Pharmaceuticals, Inc. - Market Valuation|Market Value RANI|SNYR: Market Valuation|RLYB - Market Capitalization|LEXX (Lexaria Bioscience) - Market Valuation|PULM (Pulmatrix Inc) - Market Value|Market Valuation PTHL|APM: Market Value|Market Valuation LYRA (Lyra Therapeutics, Inc.)|Market Value IBO|Market Capitalization TNFA (TNF Pharmaceuticals)|Market Value YCBD|PainReform - Market Capitalization|Market Value CYTO (altamiratherapeutics.com)|LIPO (Lipella Pharmaceuticals) - Market Valuation|Market Value OptiNose (OPTN)|PIRS (Pieris Pharmaceuticals, Inc.) - Market Capitalization|PROC - Market Capitalization|Market Capitalization PTPI|QLI - Market Value|Market Value ACELYRIN SLRN|TFFP - Market Valuation